Results 91 to 100 of about 222 (119)

First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial. [PDF]

open access: yesNat Med
Fizazi K   +20 more
europepmc   +1 more source

Nominata 2025. [PDF]

open access: yesRev Bras Ginecol Obstet
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Home - About - Disclaimer - Privacy